HK1209367A1 - Use of clostridium nexile in the treatment or prevention of rheumatoid arthritis or related diseases - Google Patents

Use of clostridium nexile in the treatment or prevention of rheumatoid arthritis or related diseases

Info

Publication number
HK1209367A1
HK1209367A1 HK15110196.4A HK15110196A HK1209367A1 HK 1209367 A1 HK1209367 A1 HK 1209367A1 HK 15110196 A HK15110196 A HK 15110196A HK 1209367 A1 HK1209367 A1 HK 1209367A1
Authority
HK
Hong Kong
Prior art keywords
prevention
treatment
rheumatoid arthritis
related diseases
clostridium nexile
Prior art date
Application number
HK15110196.4A
Other languages
Chinese (zh)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1209367A1 publication Critical patent/HK1209367A1/en

Links

HK15110196.4A 2014-09-30 2015-10-16 Use of clostridium nexile in the treatment or prevention of rheumatoid arthritis or related diseases HK1209367A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410524063.7A CN104546937B (en) 2014-09-30 2014-09-30 Clostridium nexile is treating or preventing the application in rheumatoid arthritis or its related disease

Publications (1)

Publication Number Publication Date
HK1209367A1 true HK1209367A1 (en) 2016-04-01

Family

ID=53064709

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15110196.4A HK1209367A1 (en) 2014-09-30 2015-10-16 Use of clostridium nexile in the treatment or prevention of rheumatoid arthritis or related diseases

Country Status (2)

Country Link
CN (1) CN104546937B (en)
HK (1) HK1209367A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019178494A1 (en) * 2018-03-15 2019-09-19 Evelo Biosciences, Inc. Compositions and methods for treating cancer and inflammation using tyzzerella nexilis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101310730A (en) * 2007-05-27 2008-11-26 青岛东海药业有限公司 Use of clostridium butyricum for preparing microbiological preparation for preventing and curing atrophic arthritis, ankylosing spondylitis
CN102670663B (en) * 2008-01-31 2014-10-29 青岛东海药业有限公司 Clostridium preparation and application thereof
CN101496819A (en) * 2008-01-31 2009-08-05 青岛东海药业有限公司 Eubacterium, Clostridium preparation and use thereof
AU2012225305B2 (en) * 2011-03-09 2017-06-08 Regents Of The University Of Minnesota Compositions and methods for transplantation of colon microbiota
BRPI1100857A2 (en) * 2011-03-18 2013-05-21 Alexandre Eduardo Nowill immunomodulatory agent and combinations thereof, their use and immunotherapeutic method for real time recontextualization, reprogramming and rebuilding of the immune system
WO2012142605A1 (en) * 2011-04-15 2012-10-18 Samaritan Health Services Rapid recolonization deployment agent

Also Published As

Publication number Publication date
CN104546937B (en) 2019-02-01
CN104546937A (en) 2015-04-29

Similar Documents

Publication Publication Date Title
IL283086A (en) Use of cannabidiol in the treatment of tuberous sclerosis complex
HK1209347A1 (en) Use of bacteroides dorei in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209365A1 (en) Use of bacteroides plebeius in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209349A1 (en) Use of parabacteroides merdae in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209360A1 (en) Use of bacteroides ovatus in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209350A1 (en) Use of bacteroides caccae in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209348A1 (en) Use of bacteroides thetaiotaomicron in the treatment or prevention of rheumatoid arthritis or related diseases
IL276690A (en) Neural microphysiological systems and methods of using the same
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
PL3277280T3 (en) Isomyosmine for use in the treatment of autoimmune diseases
HK1249851A1 (en) Treatment and prevention of the common cold using povidone-iodine
HK1209346A1 (en) Use of bifidobacterium bifidum in the treatment or prevention of rheumatoid arthritis or related diseases
PT3160464T (en) 6-hydroxybuspirone for use in the treatment of movement disorders
HK1209351A1 (en) Use of haemophilus parainfluenzae in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209359A1 (en) Use of megamonas hypermegale in the treatment or prevention of rheumatoid arthritis or related diseases
GB201404372D0 (en) Assay and treatment
FI3197556T3 (en) Composition for the prevention and/or treatment of allergy symptoms
HK1209363A1 (en) Use of lactobacillus crispatus in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209366A1 (en) Use of lactococcus lactis in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209357A1 (en) Use of dialister invisus in the treatment or prevention of rheumatoid arthritis or related diseases
IL249152A0 (en) Botulinum toxin for use in the treatment of paratonia
HK1209367A1 (en) Use of clostridium nexile in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209369A1 (en) Use of alistipes shahii in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209368A1 (en) Use of prevotella maculosa in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209364A1 (en) Use of actinomyces naeslundii in the treatment or prevention of rheumatoid arthritis or related diseases